Form D · Biotechnology
Q Holdings, Inc.
Salt Lake City, UT · CIK 0001366541
Offering snapshot reported Jul 27, 2012 · SEC filing
- Reported sold
- $4.02M Offering amount: $6M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Oct 13, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 27, 2012 | Initial | $4,018,047 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-181878
Offering terminated on May 31, 2012.
Up to 6,000,000 Units, each Unit consisted of 1 share of Common Stock, 1 Seven-Year Warrant exercisable at $1.00 per share and 1 Seven-Year Warrant exercisable at $2.00 per share.
Source: Form D, filed Jul 27, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven J. Borst | Executive |
| Deborah A. Eppstein | Director, Executive |
| Peter Grebow | Director |
| Peter Barton Hutt | Director |
| Dinesh C. Patel | Director |
| Linda F. Powers | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
615 Arapeen Drive Suite 102
Salt Lake City, UT, 84108
Salt Lake City, UT, 84108